Related Experiment Video
Updated: Jun 13, 2025

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
Beyond dabigatran: recognizing direct oral anticoagulants as a cause of exfoliative esophagitis
Miriam Celada-Sendino1, Margarita Fernández-de la Varga1, Carlos Ordieres-Díaz1
1UGC Aparato Digestivo, Hospital Vital Álvarez-Buylla, España.
Abstract:
The new direct oral anticoagulants, despite their efficacy and safety, may cause adverse gastrointestinal effects, such as exfoliative esophagitis or esophagitis dissecans superficialis. This adverse effect, primarily reported with dabigatran treatment, is uncommon with other anticoagulants. Clinical and endoscopic recognition is essential for the proper management of the patient.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Esophageal Varices-I: Introduction
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

